Table 3.

Changes in anthropometric and clinical measures at 12 months

Anthropometric/clinical measure	Participants, n		Mean change from baseline		Adjusted difference at follow-upa
	Control, n= 173	Intervention, n= 180	Control	Intervention	Coefficient (95% CI)	P-value
Body mass index, kg/m2	130	123	−0.19	0.002	0.18 (−0.10 to 0.47)	0.205
Body weight, kg	130	123	−0.85	−0.33	0.51 (−0.26 to 1.28)	0.192
Waist circumference, cm	130	123	0.61	0.34	−0.33 (−1.84 to 1.19)	0.671
Hip circumference, cm	130	123	−0.12	0.19	0.08 (−1.29 to 1.44)	0.914
Waist:hip ratio	130	123	0.01	0.001	0.005 (−0.01 to 0.02)	0.629
Left-hand grip, kg	130	123	−2.97	−1.57	1.06 (−0.51 to 2.64)	0.186
Right-hand grip, kg	129	123	−2.60	−1.59	0.78 (−0.87 to 2.43)	0.352
Systolic blood pressure, mm HG	130	123	−2.71	−1.21	1.61 (−2.03 to 5.25)	0.385
Diastolic blood pressure, mm HG	130	123	−3.61	−3.81	−0.05 (−2.03 to 1.94)	0.962
Resting heart rate, b.p.m.	130	123	0.12	−0.59	−0.65 (−2.57 to 1.26)	0.503
Total cholesterol, mmol/l	124	125	−0.18	−0.24	−0.04 (−0.19 to 0.11)	0.585
HDL cholesterol, mmol/l	124	125	−0.02	−0.01	−0.02 (−0.10 to 0.05)	0.540
LDL cholesterol, mmol/l	123	122	−0.13	−0.23	−0.07 (−0.20 to 0.05)	0.226
Triglycerides, mmol/l	124	125	−0.15	0.003	0.16 (−0.01 to 0.32)	0.058
Total cholesterol:HDL ratio	124	125	−0.13	−0.19	−0.01 (−0.11 to 0.10)	0.925
HbA1c, %	129	129	−0.09	−0.08	−0.001 (−0.11 to 0.11)	0.985
HbA1c, mmol/mol	129	129	−0.96	−1.24	−0.36 (−1.66 to 0.95)	0.591

^a Adjusted for stratification factors: sex, ethnicity; baseline value. Participants with missing outcome data or missing variables required for the model adjustment were excluded. CI = confidence interval. HbA1c = glycated haemoglobin. HDL = high-density lipoprotein. LDL = low-density lipoprotein.